Clinical Trial Update: Low Molecular Weight hEparin vs. Aspirin Post-partum [NA]

View source ↗

Summary

A completed clinical trial comparing low molecular weight heparin with aspirin for postpartum prevention of venous thromboembolism.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Venous Thromboembolism

Drugs mentioned

• Aspirin (Aspirin)
• Low molecular weight heparin (low molecular weight heparin)

Snippet

Sponsor: Mount Sinai Hospital, Canada | Conditions: Venous Thromboembolism | NA | Status: COMPLETED